MetaCap

Sagimet Biosciences Series A Insider Trades

NASDAQ: SGMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.08-0.54 (-5.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
9 · $4.62M
Shares bought / sold
0 / 484.31K
Net activity
Net selling $4.6 million

Sagimet Biosciences Series A insider activity

Over the last 12 months, Sagimet Biosciences Series A insiders reported 17 transactions on SEC Form 4: 0 open-market purchases and 9 sales. Insiders bought $0 and sold $4.6 million worth of stock, for net insider selling of $4.6 million. The largest seller was Kemble George, with $3.9 million in reported sales.

The most recent filing shows Kemble George (Director) reporting a transaction in 326,618 shares at $6.36 on Aug 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SGMT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SGMT insider transactions

Sagimet Biosciences Series A insider transactions
DateInsiderTypeSharesValueFiling
Aug 14, 2026Kemble GeorgeDirectorSale350,987$3.59MForm 4
Aug 14, 2026Kemble GeorgeDirectorOption exercise24,369$154.99KForm 4
Aug 14, 2026Kemble GeorgeDirectorOption exercise326,618$2.08MForm 4
Aug 11, 2026Kemble GeorgeDirectorSale20,206$201.15KForm 4
Aug 11, 2026Kemble GeorgeDirectorOption exercise10,455$66.49KForm 4
Aug 11, 2026Kemble GeorgeDirectorOption exercise9,751$62.02KForm 4
Jul 20, 2026Kemble GeorgeDirectorSale18,844$140.53KForm 4
Jul 20, 2026Rozek ElizabethChief Legal & Admin. OfficerSale10,545$81.83KForm 4
Jul 20, 2026Happel DavidPresident & CEOSale64,051$497.07KForm 4
Feb 19, 2026Chauche ThierryChief Financial OfficerAward44,000—Form 4
Feb 19, 2026Martins Eduardo BrunoChief Medical OfficerAward44,000—Form 4
Feb 19, 2026Happel DavidPresident & CEOAward128,000—Form 4
Feb 19, 2026Rozek ElizabethChief Legal & Admin. OfficerAward44,000—Form 4
Feb 10, 2026Rozek ElizabethChief Legal & Admin. OfficerSale2,622$14.05KForm 4
Feb 10, 2026Martins Eduardo BrunoChief Medical OfficerSale3,640$19.51KForm 4
Feb 10, 2026Chauche ThierryChief Financial OfficerSale1,312$7.03KForm 4
Feb 10, 2026Happel DavidPresident & CEOSale12,101$64.86KForm 4
Nov 20, 2025Kemble GeorgeExecutive ChairmanSale37,688$289.98KForm 4
Nov 4, 2025Rozek ElizabethChief Legal & Admin. OfficerAward9,855—Form 4
Jul 21, 2025Happel DavidPresident & CEOSale65,478$598.12KForm 4
Jul 21, 2025Rozek ElizabethGeneral Counsel and CCOSale10,780$98.47KForm 4
Jul 21, 2025Martins Eduardo BrunoChief Medical OfficerSale8,277$75.61KForm 4
Feb 6, 2025Rozek ElizabethGeneral Counsel and CCOAward34,000—Form 4
Feb 6, 2025Happel DavidPresident & CEOAward116,000—Form 4
Feb 6, 2025Chauche ThierryChief Financial OfficerAward17,000—Form 4
Feb 6, 2025Martins Eduardo BrunoChief Medical OfficerAward34,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related